ZA935879B - Method of inhibiting cell proliferation using apolipoprotein E. - Google Patents
Method of inhibiting cell proliferation using apolipoprotein E.Info
- Publication number
- ZA935879B ZA935879B ZA935879A ZA935879A ZA935879B ZA 935879 B ZA935879 B ZA 935879B ZA 935879 A ZA935879 A ZA 935879A ZA 935879 A ZA935879 A ZA 935879A ZA 935879 B ZA935879 B ZA 935879B
- Authority
- ZA
- South Africa
- Prior art keywords
- apolipoprotein
- cell proliferation
- inhibiting cell
- inhibiting
- proliferation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92897992A | 1992-08-12 | 1992-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935879B true ZA935879B (en) | 1994-03-11 |
Family
ID=25457115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935879A ZA935879B (en) | 1992-08-12 | 1993-08-12 | Method of inhibiting cell proliferation using apolipoprotein E. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0659085A4 (en) |
JP (1) | JPH08502730A (en) |
KR (1) | KR950702430A (en) |
AU (1) | AU673543B2 (en) |
CA (1) | CA2141598A1 (en) |
IL (1) | IL106664A0 (en) |
NZ (1) | NZ255732A (en) |
WO (1) | WO1994004178A1 (en) |
ZA (1) | ZA935879B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
IL110638A0 (en) * | 1993-08-12 | 1994-11-11 | Bio Technology General Corp | Composition for inhibiting kaposi's sarcoma |
IL120005A (en) * | 1997-01-14 | 2000-08-31 | Ramot University Authority Of | Pharmaceutical compositions for the treatment of the eye |
US6593291B1 (en) * | 1997-02-06 | 2003-07-15 | Entremed, Inc. | Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
JP2002539174A (en) * | 1999-03-17 | 2002-11-19 | エントレメッド インコーポレイテッド | Compositions and methods using LDL-like receptor ligands for the treatment of cancer and angiogenesis-related diseases |
WO2001037853A2 (en) * | 1999-11-23 | 2001-05-31 | North Shore - Long Island Jewish Health System | Methods and agents for the inhibition of smooth muscle cell proliferation |
US20020182587A1 (en) * | 2001-03-02 | 2002-12-05 | Sivaram Pillarisetti | Methods and compositions for the treatment and prevention of smooth muscle cell proliferation |
JP5706818B2 (en) * | 2008-07-01 | 2015-04-22 | コグノッシ, インコーポレイテッド | Method of treating cancer with ApoE peptide |
WO2011085110A1 (en) | 2010-01-06 | 2011-07-14 | Cognosci, Inc. | Apoe peptide dimers and uses thereof |
JP6031718B2 (en) * | 2011-09-20 | 2016-11-30 | 国立大学法人 熊本大学 | Alpha2-macroglobulin neuroprotective effect inhibitor using lipoprotein and ophthalmic composition |
JP7590010B2 (en) * | 2020-09-16 | 2024-11-26 | 国立大学法人大阪大学 | Screening method for cancer treatment drugs, immunostimulants and anticancer substances |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5473039A (en) * | 1989-08-18 | 1995-12-05 | The Scripps Research Institute | Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs |
US5168045A (en) * | 1989-08-18 | 1992-12-01 | The Scripps Research Institute | Diagnostic systems and methods using polypeptide analogs of apolipoprotein e |
EP0600875A4 (en) * | 1991-06-26 | 1995-01-25 | Bio Technology General Corp | Purification of recombinant apolipoprotein e from bacteria. |
IL110638A0 (en) * | 1993-08-12 | 1994-11-11 | Bio Technology General Corp | Composition for inhibiting kaposi's sarcoma |
-
1993
- 1993-08-12 ZA ZA935879A patent/ZA935879B/en unknown
- 1993-08-12 AU AU50072/93A patent/AU673543B2/en not_active Ceased
- 1993-08-12 NZ NZ255732A patent/NZ255732A/en unknown
- 1993-08-12 IL IL106664A patent/IL106664A0/en unknown
- 1993-08-12 CA CA002141598A patent/CA2141598A1/en not_active Abandoned
- 1993-08-12 KR KR1019950700386A patent/KR950702430A/en not_active Application Discontinuation
- 1993-08-12 EP EP93919995A patent/EP0659085A4/en not_active Withdrawn
- 1993-08-12 WO PCT/US1993/007582 patent/WO1994004178A1/en not_active Application Discontinuation
- 1993-08-12 JP JP6506399A patent/JPH08502730A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU5007293A (en) | 1994-03-15 |
NZ255732A (en) | 1997-05-26 |
CA2141598A1 (en) | 1994-03-03 |
AU673543B2 (en) | 1996-11-14 |
EP0659085A4 (en) | 1996-06-12 |
KR950702430A (en) | 1995-07-29 |
WO1994004178A1 (en) | 1994-03-03 |
IL106664A0 (en) | 1993-12-08 |
EP0659085A1 (en) | 1995-06-28 |
JPH08502730A (en) | 1996-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL108075A0 (en) | Enzyme inhibitors | |
ZA945657B (en) | Method to inhibit restenosis | |
EP0576178A3 (en) | Method of maintaining relationships between elements. | |
ZA939369B (en) | Method of milling. | |
IL101792A0 (en) | Bioreactor | |
ZA94102B (en) | Method of inhibiting viral reproduction | |
GB9305142D0 (en) | Method | |
EP0608982A3 (en) | Process for inhibiting activity of endotoxin. | |
ZA935879B (en) | Method of inhibiting cell proliferation using apolipoprotein E. | |
EP0599514A3 (en) | Pyranoquinoline derivatives as inhibitors of cell proliferation. | |
PL313740A1 (en) | Method of | |
GB9204409D0 (en) | Determination method | |
GB9209175D0 (en) | Bioreactor system | |
ZA934970B (en) | Enzyme inhibitors | |
GB9306292D0 (en) | Method | |
GR3022957T3 (en) | Arrangement for cathodic protection | |
ZA942685B (en) | Genetic stabilizing elements | |
GB9212261D0 (en) | Enzyme cloning | |
ZA939480B (en) | Enzyme inhibitor | |
AU2321088A (en) | Method for preventing or treating thrombocytopenia | |
GB9324803D0 (en) | Enzyme inhibitors | |
GB9324916D0 (en) | Sludge biocombustion | |
ZA938867B (en) | Enzyme inhibitors | |
GB9302488D0 (en) | Cathodic protection system | |
ZA942247B (en) | Method of construction |